Related Experiment Video
Updated: May 16, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders
David Castle1, Amanda L Baker, Robyn Richmond
1St. Vincent's Hospital and The University of Melbourne, Fitzroy, Victoria, Australia. david.castle@svhm.org.au
Background:
We were interested in exploring the efficacy and safety of varenicline as an adjunct to a healthy lifestyle intervention for smoking cessation among individuals with a severe mental illness.
Methods:
We used varenicline as an adjunct to a healthy lifestyle intervention in 14 smokers with a psychotic illness.
Results:
Overall, smoking cessation rates were 36% at 3 months and 42% at 6 months. The most commonly reported side effects were sleep disturbance and nausea. These tended to occur early in treatment, and patients responded to general measures of support and reassurance. Of the 14 participants, 1 dropped out because of psychiatric problems and 2 because of other side effects.
Conclusions:
Varenicline appears to be an effective adjunct to a healthy lifestyle intervention for smokers with a psychotic illness. Although the results of this open study are encouraging, replication in an adequately powered, randomized controlled trial is required before definitive conclusions can be drawn.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: MAOIs and Other Agents
COPD: Management Using Bronchodilators and Corticosteroids
Psychosis and Antipsychotic Drugs: Overview
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Antipsychotic Drugs: Typical and Atypical Agents